FRANKFURT (dpa-AFX) - After a mixed start to trading, the shares of Redcare Pharmacy clearly worked their way into the profit zone on Tuesday thanks to optimistic statements on business development in October.

The shares recently rose by 3.3 percent to 145.90 euros. As a result, they managed to rise above the 21-day line again after three days. The share recently struggled with this indicator for the short-term trend for several days. From the high since the end of 2021, which the shares had recently reached at EUR 153.80, they then retreated somewhat.

According to Baader Bank expert Volker Bosse, there was positive news about prescription drug sales in Germany following the introduction of e-prescriptions. With growth of over 130 percent in October, the momentum at the beginning of the fourth quarter had increased even further, he wrote. Warburg analyst Michael Heider sees the strong growth in prescription drugs as "a clear driver for the share".

Redcare's performance also cautiously supported the shares of competitor DocMorris, which gained around 0.8 percent on the Zurich stock exchange./tih/bek/mis